Zytiga

Zytiga (abiraterone acetate) is a prostate cancer treatment used to treat men with metastatic castration-resistant prostate cancer.

Zytiga (abiraterone acetate) is a prostate cancer treatment used to treat men with metastatic castration-resistant prostate cancer. It was approved for marketing by Janssen by the US Food and Drug Administration in 2011.


Latest Articles

Back to top